Salivary Gland Carcinoma
📧 Sign up to get email alerts when something new happens for Salivary Gland Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial [Phase 1]
This is an early-stage (Phase 1) clinical trial evaluating the combination of DS-8201a (trastuzumab deruxtecan) and AZD6738 (camonsertib) fo…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers [Phase 2]
Phase 2 trial evaluating ado-trastuzumab emtansine versus standard chemotherapy with docetaxel plus trastuzumab or trastuzumab deruxtecan in…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing [Phase 2]
This clinical trial update describes a Phase II study of advanced salivary gland carcinoma guided by molecular typing. The study status is a…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing [Phase 2]
Phase 2 clinical trial investigating precision treatment guided by molecular typing for recurrent or metastatic salivary gland carcinoma is …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study [Phase 2]
Phase 2 open-label cohort study evaluating the safety and efficacy of MRG003, with or without Putrelimab, in recurrent or metastatic salivar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Immune Biomarker Study for Salivary Gland Carcinoma
An ongoing immune biomarker study at University of Erlangen-Nürnberg Medical School is investigating immune biomarkers in salivary gland car…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region
This entry indicates a prospective registry study on implementing simultaneous postoperative radiochemotherapy for locally advanced salivary…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer [Phase 2]
This clinical trial update reports the Phase 2 study of pemetrexed plus pembrolizumab for recurrent/metastatic salivary gland carcinoma, wit…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of androgen deprivation therapy and pembrolizumab for advanced androgen receptor–positive …
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma [Phase 1, Phase 2]
Clinical trial update for VMD-928 as a monotherapy and in combination with pembrolizumab to treat TrkA overexpression-driven solid tumors or…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers [Phase 2]
A Phase 2 trial evaluating darolutamide for testosterone-driven salivary gland cancers is active but not currently recruiting. The study enc…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer [Phase 1]
This document reports the completion of a Phase Ib trial evaluating erlotinib given before surgery in patients with recurrent head and neck …
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas [Phase 2]
A Phase 2 clinical trial evaluating postoperative concurrent chemoradiotherapy for high-risk salivary gland carcinomas has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer [Phase 2]
Phase 2 trial evaluating nivolumab and ipilimumab for metastatic/recurrent major and minor salivary gland carcinomas; status/results are not…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for nivolumab in recurrent or metastatic salivary gland carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma [Phase 2]
Phase 2 trial evaluating pazopanib in patients with progressive recurrent and/or metastatic salivary gland carcinoma has completed.
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: PSMA-PET Imaging for Advanced ACC/SDC [NA]
This entry notes the completion of a clinical trial evaluating PSMA-PET imaging in advanced adenoid cystic carcinoma and salivary duct carci…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers [Phase 2]
This ClinicalTrials.gov update reports the results of a Phase 2 trial of lapatinib in patients with recurrent and/or metastatic adenoid cyst…